Journals / Acta Medica Alanya / 2021 / Cilt: 5 - Sayı: 2

Comparison between R2CHA2DS2-VASc Score and CHA2DS2- VASc Score to Predict Acute Stent Thrombosis in Patients with After Primary Percutaneous Coronary Intervention

Primer Perkütan Koroner Girişim Yapılan Hastalarda Akut Stent Trombozunu Öngörmek İçin R2CHA2DS2-VASc Skoru ile CHA2DS2-VASc Skorlarının Karşılaştırılması

Pages
150–156
Publication Date
2022-09-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

TheR2CHA2DS2-VASc score ≥2 was used as a predictor of the AST with a sensitivity of65% and specificity of 89%.Conclusions: The R2CHA2DS2-VASc score is a simple, cheap, and easilyaccessible score that can predict AST.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Acute stent thrombosis (AST) is an important complication resulting fromsudden vascular occlusion after stent implantation, especially in patients with STsegment elevation myocardial infarction (STEMI).
📊
Key Findings & Data:It occurs in about 1% of thepatients after primary percutaneous coronary intervention.
💡
Conclusion & Impact:TheR2CHA2DS2-VASc score ≥2 was used as a predictor of the AST with a sensitivity of65% and specificity of 89%.Conclusions: The R2CHA2DS2-VASc score is a simple, cheap, and easilyaccessible score that can predict AST.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Acute stent thrombosis (AST) is an important complication resulting fromsudden vascular occlusion after stent implantation, especially in patients with STsegment elevation myocardial infarction (STEMI). It occurs in about 1% of thepatients after primary percutaneous coronary intervention. The CHA2DS2-VAScscore is easily applied in daily practice and the components of this score are similarto common risk factors of the AST. Chronic renal disease has a hypercoagulablestate and this condition is associated with an increased risk of AST in STEMI. Sincethe CHA2DS2-VASc score is insufficient to assess the risk of AST in patients withrenal dysfunction, we aimed to investigate the prognostic significance of the modifiedscore, R2CHA2DS2-VASc score in patients with AST.Methods:This cross-sectional study retrospectively included 56 patients withASTand 1493 patients without AST after STEMI. The CHA2DS2-VASc and R2CHA2DS2-VASc scores were compared between the two groups.Results:The median CHA2DS2-VASc and R2CHA2DS2-VASc scores weresignificantly higher in the AST group (P <0.001, P <0.001, respectively). TheR2CHA2DS2-VASc score ≥2 was used as a predictor of the AST with a sensitivity of65% and specificity of 89%.Conclusions: The R2CHA2DS2-VASc score is a simple, cheap, and easilyaccessible score that can predict AST.

Özet

Amaç: Akut stent trombozu (AST), özellikle ST segment yükselmesi olan miyokard infarktüsü (STYMI) hastalarında stent yerleştirildikten sonra ani damar tıkanıklığı sonucu oluşan önemli bir komplikasyondur. Primer perkütan koroner girişim sonrası hastaların yaklaşık% 1'inde ortaya çıkar. CHA2DS2-VASc skoru günlük pratikte kolayca uygulanır ve bu skorun bileşenleri AST'nin risk faktörlerine benzer. Kronik böbrek hastalığında pıhtılaşmaya meyilli bir duruma yol açabilir ve bu durum STYMI' da artmış AST riski ile ilişkilidir. CHA2DS2-VASc skoru renal disfonksiyonlu hastalarda yetersiz olduğundan AST'li hastalarda modifiye skor olan R2CHA2DS2- VASc skorunun prognostik önemini araştırmayı amaçladık. Yöntem: STYMI sonrası 56 AST' li hasta ve AST'siz 1493 hasta retrospektif olarak bu kesitsel çalışmaya dahil edildi. CHA2DS2-VASc skoru ve R2CHA2DS2-VASc skoru iki grup arasında karşılaştırıldı. Bulgular: Medyan CHA2DS2-VASc skoru ve medyan R2CHA2DS2-VASc skoru AST grubunda anlamlı olarak daha yüksekti (P <0.001, P <0.001). R2CHA2DS2- VASc skoru ≥2 iken %65 duyarlılık ve % 89 özgüllük ile AST' nin bir prediktörü olarak kullanılabilir. Sonuç: R2CHA2DS2-VASc skoru, AST' yi tahmin edebilen basit, ucuz ve kolay erişilebilir bir skorlamadır.

🔖

Cite This Article

ZORLU, Ç., KURMUŞ, Ö. (2022). Comparison between R2CHA2DS2-VASc Score and CHA2DS2- VASc Score to Predict Acute Stent Thrombosis in Patients with After Primary Percutaneous Coronary Intervention. Acta Medica Alanya, Cilt: 5 - Sayı: 2, 150–156. https://ajindex.com/articles/425785

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Armstrong EJ, Feldman DN, Wang TY, Kaltenbach LA, Yeo KK, Wong SC, et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv. 2012;5(2):131-40. PMID: 22361596
  2. Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J. 2015;36(47):3320-31. PMID: 26417060. 3. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53(16):1399-409. PMID: 19371823
  3. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45(7):995-8. PMID: 15808753
  4. Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD. Stent thrombosis: a clinical perspective. JACC Cardiovasc Interv. 2014;7(10):1081-92. PMID: 25341705
  5. Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, et al. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis. 2014;237(2):504-13. PMID: 25463082
  6. Chua SK, Lo HM, Chiu CZ, Shyu KG. Use of CHADS₂ and CHA₂DS₂-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry. PLoS One. 2014;9(10):e111167. PMID: 25343586
  7. Li Y, Wang J, Lv L, Xu C, Liu H. Usefulness of the CHADS2 and R2CHADS2 scores for prognostic stratification in patients with coronary artery disease. Clin Interv Aging. 2018;13:565-71. PMID: 29670341
  8. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909-45. PMID: 19004841
  9. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):23